O'Keeffe Charles B

Insider Buys Quantity –
32
2022-11-15SaleCatalyst Pharmaceuticals, Inc.
CPRX
director
87,985
0.0849%
$16.04$1.41M-8.62%
2020-09-30PurchaseCatalyst Pharmaceuticals, Inc.
CPRX
director
14,000
0.0136%
$2.99$41,860+50.34%
2019-10-11PurchaseCatalyst Pharmaceuticals, Inc.
CPRX
director
20,000
0.0094%
$2.35$46,950-9.11%
2018-12-14PurchaseCatalyst Pharmaceuticals, Inc.
CPRX
director
40,000
0.0416%
$2.50$100,000+89.74%
2018-06-07PurchaseCatalyst Pharmaceuticals, Inc.
CPRX
director
10,000
0.0096%
$3.31$33,149-7.16%
2018-06-01PurchaseCatalyst Pharmaceuticals, Inc.
CPRX
director
10,000
0.01%
$3.74$37,360-14.46%
2016-07-12PurchaseCatalyst Pharmaceuticals, Inc.
CPRX
director
40,000
0.0488%
$0.81$32,544+43.75%
2016-04-26PurchaseCatalyst Pharmaceuticals, Inc.
CPRX
director
40,000
0.0457%
$0.60$23,840+73.02%
2016-03-16PurchaseCatalyst Pharmaceuticals, Inc.
CPRX
director
20,000
0.0243%
$1.11$22,124-0.91%
2016-02-01PurchaseCatalyst Pharmaceuticals, Inc.
CPRX
director
10,000
0.0117%
$1.86$18,650-43.23%
2016-01-08PurchaseCatalyst Pharmaceuticals, Inc.
CPRX
director
10,000
0.0123%
$1.94$19,370-43.16%
2015-12-23PurchaseCatalyst Pharmaceuticals, Inc.
CPRX
director
10,000
0.0118%
$2.41$24,087-55.87%
2015-11-19PurchaseCatalyst Pharmaceuticals, Inc.
CPRX
director
10,000
0.0116%
$2.30$22,964-53.75%
2015-10-01PurchaseCatalyst Pharmaceuticals, Inc.
CPRX
director
20,000
0.0242%
$2.85$57,000-59.33%
2015-04-30PurchaseCatalyst Pharmaceuticals, Inc.
CPRX
director
20,000
0.0254%
$3.29$65,880-1.27%
2015-04-24PurchaseCatalyst Pharmaceuticals, Inc.
CPRX
director
10,000
0.0126%
$3.80$37,999-14.36%
2015-01-13PurchaseCatalyst Pharmaceuticals, Inc.
CPRX
director
20,000
0.0275%
$3.00$59,968+27.53%
2014-05-19PurchaseCatalyst Pharmaceuticals, Inc.
CPRX
director
20,000
0.0302%
$1.83$36,582+57.38%
2014-04-16PurchaseCatalyst Pharmaceuticals, Inc.
CPRX
director
10,000
0.015%
$2.02$20,199+34.98%
2014-02-05PurchaseCatalyst Pharmaceuticals, Inc.
CPRX
director
20,000
0.0369%
$1.81$36,198+32.04%